Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281617140> ?p ?o ?g. }
- W4281617140 endingPage "2717" @default.
- W4281617140 startingPage "2717" @default.
- W4281617140 abstract "Prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET-CT) is a novel imaging modality used to stage recurrent prostate cancer. It has the potential to improve prognostication and ultimately guide the timing of treatment for men with recurrent prostate cancer. This study aims to assess the clinical impact of PSMA PET-CT by analyzing its predictive value of treatment progression after 3 years of follow-up. In this prospective cohort study of 100 men, patients received a PSMA PET-CT for restaging of their disease which was used by a multi-disciplinary team to make a treatment decision. The primary endpoint was treatment progression. This was defined as the addition or change of any treatment modalities such as androgen deprivation therapy (ADT), radiation therapy or chemotherapy. The median follow-up time was 36 months (IQR 24–40 months). No treatment progression was found in 72 (75%) men and therefore 24 (25%) patients were found to have treatment progression. In men with a negative PSMA PET-CT result, 5/33 (15.1%) had treatment progression and 28/33 (84.8%) had no treatment progression. In conclusion, clinical decisions made with PSMA PET-CT results led to 75% of men having no treatment progression at 3 years of follow-up. In men with negative PSMA PET-CT results, this increased to 85% of men." @default.
- W4281617140 created "2022-06-13" @default.
- W4281617140 creator A5010820525 @default.
- W4281617140 creator A5014703177 @default.
- W4281617140 creator A5021906019 @default.
- W4281617140 creator A5026945652 @default.
- W4281617140 creator A5044519122 @default.
- W4281617140 creator A5060180287 @default.
- W4281617140 creator A5064536913 @default.
- W4281617140 creator A5068804442 @default.
- W4281617140 creator A5072953177 @default.
- W4281617140 creator A5081221251 @default.
- W4281617140 date "2022-05-31" @default.
- W4281617140 modified "2023-10-18" @default.
- W4281617140 title "PSMA PET-CT Imaging Predicts Treatment Progression in Men with Biochemically Recurrent Prostate Cancer—A Prospective Study of Men with 3 Year Follow Up" @default.
- W4281617140 cites W2053554578 @default.
- W4281617140 cites W2093867637 @default.
- W4281617140 cites W2103444700 @default.
- W4281617140 cites W2116511683 @default.
- W4281617140 cites W2117792530 @default.
- W4281617140 cites W2150467310 @default.
- W4281617140 cites W2163470211 @default.
- W4281617140 cites W2487033212 @default.
- W4281617140 cites W2673309218 @default.
- W4281617140 cites W2752847179 @default.
- W4281617140 cites W2769219206 @default.
- W4281617140 cites W2801600457 @default.
- W4281617140 cites W2896060946 @default.
- W4281617140 cites W2897445406 @default.
- W4281617140 cites W2913023403 @default.
- W4281617140 cites W2919514203 @default.
- W4281617140 cites W2928931548 @default.
- W4281617140 cites W2943710987 @default.
- W4281617140 cites W2947365942 @default.
- W4281617140 cites W2955918565 @default.
- W4281617140 cites W2989413482 @default.
- W4281617140 cites W3011546611 @default.
- W4281617140 cites W3012827461 @default.
- W4281617140 cites W3087977689 @default.
- W4281617140 cites W3088359655 @default.
- W4281617140 cites W3135538217 @default.
- W4281617140 cites W3138602885 @default.
- W4281617140 cites W3142721885 @default.
- W4281617140 cites W3171818150 @default.
- W4281617140 cites W3200187442 @default.
- W4281617140 cites W4210744928 @default.
- W4281617140 cites W4220905171 @default.
- W4281617140 doi "https://doi.org/10.3390/cancers14112717" @default.
- W4281617140 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35681697" @default.
- W4281617140 hasPublicationYear "2022" @default.
- W4281617140 type Work @default.
- W4281617140 citedByCount "6" @default.
- W4281617140 countsByYear W42816171402022 @default.
- W4281617140 countsByYear W42816171402023 @default.
- W4281617140 crossrefType "journal-article" @default.
- W4281617140 hasAuthorship W4281617140A5010820525 @default.
- W4281617140 hasAuthorship W4281617140A5014703177 @default.
- W4281617140 hasAuthorship W4281617140A5021906019 @default.
- W4281617140 hasAuthorship W4281617140A5026945652 @default.
- W4281617140 hasAuthorship W4281617140A5044519122 @default.
- W4281617140 hasAuthorship W4281617140A5060180287 @default.
- W4281617140 hasAuthorship W4281617140A5064536913 @default.
- W4281617140 hasAuthorship W4281617140A5068804442 @default.
- W4281617140 hasAuthorship W4281617140A5072953177 @default.
- W4281617140 hasAuthorship W4281617140A5081221251 @default.
- W4281617140 hasBestOaLocation W42816171401 @default.
- W4281617140 hasConcept C121608353 @default.
- W4281617140 hasConcept C126322002 @default.
- W4281617140 hasConcept C126838900 @default.
- W4281617140 hasConcept C143998085 @default.
- W4281617140 hasConcept C188816634 @default.
- W4281617140 hasConcept C203092338 @default.
- W4281617140 hasConcept C20417620 @default.
- W4281617140 hasConcept C2775842073 @default.
- W4281617140 hasConcept C2776235491 @default.
- W4281617140 hasConcept C2777899217 @default.
- W4281617140 hasConcept C2779256057 @default.
- W4281617140 hasConcept C2779466945 @default.
- W4281617140 hasConcept C2780192828 @default.
- W4281617140 hasConcept C2909113890 @default.
- W4281617140 hasConcept C535046627 @default.
- W4281617140 hasConcept C71924100 @default.
- W4281617140 hasConceptScore W4281617140C121608353 @default.
- W4281617140 hasConceptScore W4281617140C126322002 @default.
- W4281617140 hasConceptScore W4281617140C126838900 @default.
- W4281617140 hasConceptScore W4281617140C143998085 @default.
- W4281617140 hasConceptScore W4281617140C188816634 @default.
- W4281617140 hasConceptScore W4281617140C203092338 @default.
- W4281617140 hasConceptScore W4281617140C20417620 @default.
- W4281617140 hasConceptScore W4281617140C2775842073 @default.
- W4281617140 hasConceptScore W4281617140C2776235491 @default.
- W4281617140 hasConceptScore W4281617140C2777899217 @default.
- W4281617140 hasConceptScore W4281617140C2779256057 @default.
- W4281617140 hasConceptScore W4281617140C2779466945 @default.
- W4281617140 hasConceptScore W4281617140C2780192828 @default.
- W4281617140 hasConceptScore W4281617140C2909113890 @default.
- W4281617140 hasConceptScore W4281617140C535046627 @default.
- W4281617140 hasConceptScore W4281617140C71924100 @default.